ArticleOpen forum infectious diseases2022

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era.

Erin K McCreary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.